Objective:To study the clinical effect of drugs combined with extracorporeal shock wave in the treatment of type ⅢA prostatitis. Methods:We collected 96 patients who were diagnosed with type ⅢA prostatitis clinically, and these patients were randomly divided into three groups, i.e.,drug treatment group, ESWT group and combination therapy group. The three groups were treated with drugs,ESWT and drugs combined with ESWT respectively. The total treatment time was 4 weeks. The scores of NIH-CPSI, IPSS, NRS-11 and the numbers of white blood cells(WBC) in prostatic secretion(EPS) were recorded before and after treatment. The therapeutic effect was evaluated by comparing the changes of each index before and after the different treatments and the curative rate. Results:After 4 weeks of treatment, the scores of CPSI, IPSS, NRS-11 and numbers of WBC in EPS were significantly decreased in all the three groups compared with those before treatment. After treatment,the CPSI score in the combination therapy group was significantly lower than that in drug and ESWT groups(P<0.05), but there was no significant difference in CPSI score between the drug group and ESWT group. There were no significant differences between each group in IPSS score. The NRS-11 scores of the ESWT group and the combination therapy group were significantly lower than those in the drug group(P<0.05), but there was no significant difference between the ESWT group and the combination therapy group in NRS-11 score. The WBC in the EPS of the ESWT group was significantly higher than that in the drug group and combination therapy group. Patients with CPSI score <9 were recognized as curative standard, the curative rate was significantly different in the three groups. The curative rate of the combined group was 86.11%, which was significantly higher than that of the other two groups. Conclusion:The combination of drug treatment and ESWT can improve prostatitis-related symptoms obviously, relieve the pelvic area pain, and reduce the amount of WBC in EPS, which has a higher curative rate than that of drug therapy or ESWT approach alone.
 PROPERT K J,ALEXANDER R B,NICKEL J C,et al.Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome[J].Urology,2016,59(6):870-876.
 KRIEGER J N,JACOBS R R,ROSS S O.Does the chronic prostatitis/pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia?[J].J Urol,2000,164(5):1554-1558.
 ZIMMERMAN R,CUMPANAS A,HOELTL L,et al.Extracorporeal shock-wave therapy for treating chronic pelvic pain syndrome:a feasibility study and the first clinical results[J].Bju International,2008,102(8):976-980.
 WANG H J,CHENG J H,CHUANG Y C.Potential applications of low-energy shock waves in functional urology[J].Int J Urol,2017,24(8):573-581.
 REES J,ABRAHAMS M,DOBLE A,et al.Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome:a consensus guideline[J].Bju International,2015,116(4):509-525.
 ZIMMERMAN R,CUMPANAS A,MICLEA F,et al.Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males:a randomised,double-blind,placebo-controlled study[J].Eur Urol,2009,56(3):418-424.
 ZIMMERMAN R,CUMPANAS A,JANETSCHEK G,et al.MP03.14:One-year follow-up of extracorporeal shock wave therapy(ESWT) for chronic pelvic pain syndrome(CPPS) in a randomized placebo-controlled double blind study[J].Urology,2010,76(3):S27-S27.
 MITTERMAYR R,ANTONIC V,HARTINGER J,et al.Extracorporeal shock wave therapy(ESWT) for wound healing:technology,mechanisms,and clinical efficacy[J].Wound Repair Regen,2012,20(4):456-465.
 KODAMA T,DOUKAS A G,HAMBLIN M R.Shock wave-mediated molecular delivery into cells[J].Biochim Biophys Acta,2002,1542(1-3):186.